Skip to content
SeoulCoslab
Regulations & Compliance

Korea's Functional Cosmetics Registration, Explained

What counts as a functional cosmetic in Korea, when a product needs MFDS review or only a report, who files, and what the label must then say.

Published October 29, 2026Seoul CoslabLast reviewed October 29, 2026
A stack of blank documents in a clear sleeve and an open ring binder on a wooden lab bench, beside two white tubes and a beaker of white cream

A functional cosmetic in Korea is a product whose claim falls into one of eleven categories in the Enforcement Rule of the Cosmetics Act, such as brightening or UV protection. Before sale in Korea, each goes through what brands call functional cosmetics registration: a Ministry of Food and Drug Safety (MFDS) review or, in listed cases, a report.

The rule itself uses two words, review (심사) and report (보고), and the difference between them decides how much evidence a product needs. This article is orientation rather than a compliance opinion, and the primary sources are listed at the end.

What Counts as a Functional Cosmetic in Korea?

A product counts as a functional cosmetic in Korea when what it claims to do falls into one of the eleven categories listed in Article 2 of the Enforcement Rule. The ingredient story around it does not decide the question.

#FunctionScope note in the rule
1Helps brighten the skin by preventing melanin deposition
2Helps brighten the skin by lightening the colour of melanin already deposited
3Relieves or improves wrinkles by giving the skin elasticity
4Helps the skin tan evenly by protecting it from strong sunlight
5Protects the skin from UV rays by blocking or scattering them
6Changes the colour of hairIncludes bleaching and decolouring; temporary colour is excluded
7Removes body hairPhysical removal is excluded
8Helps relieve hair-loss symptomsProducts that make hair look thicker physically, for example by coating it, are excluded
9Helps relieve acne-prone skinLimited to the body-cleansing product type the rule defines (인체 세정용 제품류)
10Helps improve itching and similar discomfort by restoring skin barrier function
11Helps lighten the red lines left by stretch marks

A claim outside that list does not make the product a functional cosmetic. Moisturising, soothing and cleansing are ordinary cosmetic claims in Korea, and a product making only those claims needs neither a review nor a report.

The edges are where projects get caught. A moisturising claim is general, while wording that promises to ease itching by restoring the barrier reads as category 10, so a few words can move a barrier cream from one side of the line to the other. An acne claim can be filed as functional only on a product of the body-cleansing type (인체 세정용 제품류) the rule names. And hair-loss wording, which our guide to scalp care development treats as the point where care turns into treatment, is functional in Korea only in one narrow form, helping to relieve hair-loss symptoms (category 8), with an exclusion attached. Settle the claim set before the brief, because it decides which of these lines the product sits on.

Review or Report: Which Path Applies?

A functional cosmetic takes the report path in the three cases Article 10 of the Enforcement Rule lists, and every other functional product goes through review under Article 9. The report cases are a match with an item MFDS has published; under certain conditions, a match with an already reviewed product that shares its responsible distributor, its research institute or the manufacturer that designed, developed and produced it; and a combination of reviewed UV actives with notified brightening or wrinkle actives that meets the rule's conditions. One or the other comes before sale, and both are filed product by product with the President of the National Institute of Food and Drug Safety Evaluation, which sits under MFDS.

Review (심사)Report (보고)
When it appliesA functional product that does not qualify for a reportThree cases, set out below: a match with an item MFDS has published; under certain conditions, a match with an already reviewed product that shares its responsible distributor, its research institute or the manufacturer that designed, developed and produced it; or a combination of reviewed UV actives with notified brightening or wrinkle actives that meets the rule's conditions
What is submittedA dossier: origin, safety, efficacy, UV data where relevant, specification and test method (parts can be omitted where MFDS has published them)A report document instead of the dossier
Who receives itNational Institute of Food and Drug Safety EvaluationNational Institute of Food and Drug Safety Evaluation
UnitEach productEach product

The report path covers three situations under Article 10:

  • The product matches an MFDS notice. The type and content of the active ingredient, the efficacy, the directions and dosage, and the specification and test method are all the same as an item MFDS has published.
  • The product matches an already reviewed product with a shared distributor, institute or manufacturer. The earlier reviewed product shares the product's responsible distributor or research institute, or comes from the same manufacturer where that manufacturer designed, developed and produced it, and the two have the same type, grade and content of the active raw material, the same efficacy, the same product specification and test method, the same directions and dosage, and the same dosage form. The business filing the report need not be the one that held the earlier review; what links the two products is that shared responsible distributor, research institute or manufacturer. The rule treats some near matches as the same, such as a measured SPF that falls below the reviewed value by no more than a set margin, a specification that differs only in pH, and, for some categories, liquid, lotion and cream forms. For categories 1 to 3 and 8 to 11, this path applies only where the earlier reviewed product proved its efficacy in a comparison against a control group.
  • The product combines reviewed UV actives with notified brightening or wrinkle actives. Certain products combine the UV-protection ingredients of an already reviewed product with the notified ingredients of a brightening or wrinkle-improvement item. Whether a given combination qualifies has to be checked against the rule itself.

The practical consequence is that, for the first report case, the notice decides the ingredient and its content. A product built on an ingredient outside the notice can still be functional, but it goes through review with its own safety and efficacy data, unless it qualifies under the second or third report case above. This is why, as the peptide serum guide explains, a peptide product typically carries a wrinkle-improvement claim through a notified active such as adenosine rather than through the peptide.

Who Files, and What the Dossier Contains

Under Article 9 of the Enforcement Rule, a review can be requested by a manufacturer, a responsible distributor (책임판매업자, the business that places the product on the Korean market), or a university or research institute. In practice, for a product sold in Korea, the filing sits with the Korean manufacturer or the responsible distributor.

A review dossier contains:

  • Origin and development history of the product.
  • Safety data: single-dose toxicity, primary skin irritation, eye mucosa irritation, sensitisation, phototoxicity and photosensitisation, and a human patch test.
  • Efficacy data: efficacy studies and human application studies.
  • UV data for UV-protection products, supporting the SPF and PA values.
  • Specification and test methods for the product.

Where MFDS has published the ingredient and its content for an item, the first four parts can be omitted. Where it has published the specification and test method, the last part can be omitted. That is the difference in workload between a product built on a notified active and one built on something new.

Because both paths are tied to the active, its content, the directions and the test method, those are decisions to fix before filing. If any of them changes after filing, raise it with the filer before the change reaches production. The test method links the filing to the batch records kept for each run, which our cosmetic quality control and testing in Korea covers.

What Changes on the Label

Article 19 of the Enforcement Rule requires a functional cosmetic to carry, on its packaging, the efficacy and the directions and dosage that were reviewed or reported. The printed claim is therefore the filed claim. Marketing copy that goes further than the filed wording is a separate claim, and it is judged on its own.

Categories 8 to 11 (hair loss, acne, barrier and itching, stretch marks) also carry a statement that the product is not a medicinal product for the prevention or treatment of disease. In Korean the wording is 질병의 예방 및 치료를 위한 의약품이 아님, and it tells the reader the product is a cosmetic.

For artwork, this means the functional wording is set by the filing and the rest of the pack is written around it. If the artwork is drawn first and the filing comes afterwards, a reprint is the usual result.

What a Korean Functional Claim Does Not Do Abroad

The review and the report are Korean procedures. The Enforcement Rule addresses those who intend to sell a product as a recognised functional cosmetic (기능성화장품으로 인정받아 판매 등을 하려는 자). A Korean review result is evidence for Korea. It is not a filing anywhere else.

Each destination reads the same words under its own rules, and the outcome can differ. Sun care is the clearest case: in Korea it is a functional cosmetic, while Korean sunscreen manufacturing for export markets sets out how the US and the EU each handle sunscreen under their own rules. Brightening, wrinkle and hair-loss wording each need the same check against the destination market's rules, and our guide to regulated, certifiable and self-declared claims covers the marketing side of that question. The market pages, such as manufacturing in Korea for the European Union and manufacturing in Korea for the United States market, set out what entry involves.

The active chosen for a Korean filing also has to be permitted in each destination market, at the content the formula uses. A brand selling in Korea and abroad should treat the Korean functional version and the export version as one specification checked twice, rather than assume the Korean result carries over.

If the product will not be sold in Korea, this procedure does not stand in for the rules of the market where it will be sold. Which Korean export documents the product then needs is a separate question, covered in what Korean cosmetics export documents prove.

What We Do and What We Do Not Do

  • We coordinate the dossier within the project scope. The filing sits with the Korean manufacturer or responsible distributor, and we work with our partner manufacturer on what goes into it, as part of cosmetic formulation development in Korea.
  • We do not promise a result or a timeline. The review is decided by the National Institute of Food and Drug Safety Evaluation, and a launch date planned around an assumed outcome is the date that moves when the review takes longer.
  • We do not decide what a claim means in your market. Within the project scope, we go through the claim set and the Korean categories with you and the partner manufacturer; what the claim means abroad is governed by the destination market's own rules.
  • We are not your legal adviser. This article is orientation, with its primary sources listed at the end.

For a functional serum, Korean serum and ampoule manufacturing covers the product side, and for a functional sunscreen, Korean sunscreen ODM, OEM and private label manufacturing does the same.

Frequently Asked Questions

Is a functional cosmetic a drug in Korea?

No. A functional cosmetic is a category under the Cosmetics Act, reviewed or reported through the MFDS system, and it is sold as a cosmetic. For hair-loss, acne, barrier and stretch-mark products, the label also states that the product is not a medicinal product for the prevention or treatment of disease.

Can a peptide or other hero ingredient carry a functional claim?

Usually not on its own. The functional claim normally rests on an active MFDS has notified, at the content the notice sets, and the claim belongs to that active. A product built on another ingredient goes through review with its own data, unless it qualifies for a report under the conditions Article 10 sets.

This is why a formula can pair a hero ingredient with a notified active that carries the claim. The niacinamide serum guide describes the pattern for brightening.

Do I need a functional cosmetics review if I only export?

Not automatically. The rule is framed around selling a product as a recognised functional cosmetic, so an export-only case is not settled by the rule alone; confirm it with the Korean manufacturer or responsible distributor.

If you will not sell in Korea, the Korean procedure does not replace the rules of your destination market, and the export documents your product needs should be confirmed separately.

Is SPF a functional claim in Korea?

Yes. Protecting the skin from UV rays is one of the eleven functional categories, so a sun protection claim goes through testing and a review or report before it can be printed.

Does a Korean functional registration let me make the same claim in the EU or US?

No. A Korean review or report is a Korean procedure and is not a filing in any other market. The EU and the US each judge the claim under their own rules. Check the claim and the active against each destination market before the artwork is drawn.

Sources
  1. Enforcement Rule of the Cosmetics Act (화장품법 시행규칙) — Ministry of Government Legislation (Korea Law Information Center)
  2. MFDS Notice on the Review of Functional Cosmetics (기능성화장품 심사에 관한 규정) — Ministry of Government Legislation (Korea Law Information Center)
  3. Cosmetic Regulatory Framework in Korea — Ministry of Food and Drug Safety, Republic of Korea

This page is general information for manufacturing planning. It is not legal or regulatory advice, it has no legal effect, and no rights can be derived from it. Requirements change by market and over time — before acting on anything here, confirm the current position with the authority concerned or with qualified counsel.

Start Your Product Brief

Let’s Create
What’s Next in Beauty.

Start Your Product Brief →